(MG) Mistras - Ratings and Ratios
Inspection, Monitoring, Sensors, Engineering, Software
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 41.6% |
| Value at Risk 5%th | 58.1% |
| Relative Tail Risk | -15.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.78 |
| Alpha | 23.61 |
| CAGR/Max DD | 0.84 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.587 |
| Beta | 0.843 |
| Beta Downside | 0.882 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.78% |
| Mean DD | 15.75% |
| Median DD | 14.11% |
Description: MG Mistras October 28, 2025
Mistras Group, Inc. (NYSE: MG) delivers technology-enabled asset protection across the United States, the Americas, Europe, and APAC, offering non-destructive testing, inline pipeline inspection, plant-condition-management software, and a broad suite of maintenance, engineering, and subsea services.
According to its FY 2023 Form 10-K, the company generated approximately $1.2 billion in revenue, with an adjusted EBITDA margin of roughly 12 % and a backlog of $1.5 billion, indicating a solid order pipeline into 2025. The firm reported a 5 % year-over-year increase in service revenue, driven largely by growth in its digital condition-monitoring platform.
Key drivers for Mistras include rising capital-expenditure cycles in oil & gas and power generation, heightened regulatory scrutiny on infrastructure safety, and accelerating adoption of digital inspection technologies (e.g., drones and AI-based analytics). The global NDT market is projected to expand at a 6-7 % CAGR through 2030, providing a favorable tailwind for the company’s diversified service portfolio.
For a deeper, data-rich assessment of MG’s valuation dynamics, you might explore ValueRay’s analytical tools to complement your own due-diligence.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (18.1m TTM) > 0 and > 6% of Revenue (6% = 42.9m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -2.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.62% (prev 10.58%; Δ 5.04pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 26.5m > Net Income 18.1m (YES >=105%, WARN >=100%) |
| Net Debt (206.6m) to EBITDA (69.7m) ratio: 2.96 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (31.9m) change vs 12m ago 0.69% (target <= -2.0% for YES) |
| Gross Margin 29.34% (prev 27.84%; Δ 1.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 124.6% (prev 134.0%; Δ -9.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.57 (EBITDA TTM 69.7m / Interest Expense TTM 14.9m) >= 6 (WARN >= 3) |
Altman Z'' 1.61
| (A) 0.19 = (Total Current Assets 237.5m - Total Current Liabilities 125.8m) / Total Assets 596.3m |
| (B) 0.00 = Retained Earnings (Balance) 2.96m / Total Assets 596.3m |
| (C) 0.07 = EBIT TTM 38.3m / Avg Total Assets 574.0m |
| (D) -0.08 = Book Value of Equity -27.9m / Total Liabilities 368.4m |
| Total Rating: 1.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.61
| 1. Piotroski 4.0pt |
| 2. FCF Yield 0.36% |
| 3. FCF Margin 0.29% |
| 4. Debt/Equity 1.03 |
| 5. Debt/Ebitda 2.96 |
| 6. ROIC - WACC (= 1.51)% |
| 7. RoE 8.63% |
| 8. Rev. Trend 47.44% |
| 9. EPS Trend 58.40% |
What is the price of MG shares?
Over the past week, the price has changed by +6.76%, over one month by -5.16%, over three months by +29.85% and over the past year by +35.42%.
Is MG a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17 | 38.1% |
| Analysts Target Price | 17 | 38.1% |
| ValueRay Target Price | 13.2 | 7.4% |
MG Fundamental Data Overview December 11, 2025
P/E Trailing = 20.8772
P/E Forward = 19.7628
P/S = 0.5248
P/B = 1.6051
P/EG = 0.8563
Beta = 1.015
Revenue TTM = 715.3m USD
EBIT TTM = 38.3m USD
EBITDA TTM = 69.7m USD
Long Term Debt = 189.2m USD (from longTermDebt, last quarter)
Short Term Debt = 30.5m USD (from shortTermDebt, last quarter)
Debt = 234.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 206.6m USD (from netDebt column, last quarter)
Enterprise Value = 582.0m USD (375.4m + Debt 234.4m - CCE 27.8m)
Interest Coverage Ratio = 2.57 (Ebit TTM 38.3m / Interest Expense TTM 14.9m)
FCF Yield = 0.36% (FCF TTM 2.10m / Enterprise Value 582.0m)
FCF Margin = 0.29% (FCF TTM 2.10m / Revenue TTM 715.3m)
Net Margin = 2.53% (Net Income TTM 18.1m / Revenue TTM 715.3m)
Gross Margin = 29.34% ((Revenue TTM 715.3m - Cost of Revenue TTM 505.4m) / Revenue TTM)
Gross Margin QoQ = 32.59% (prev 29.10%)
Tobins Q-Ratio = 0.98 (Enterprise Value 582.0m / Total Assets 596.3m)
Interest Expense / Debt = 1.44% (Interest Expense 3.38m / Debt 234.4m)
Taxrate = 22.34% (3.80m / 17.0m)
NOPAT = 29.7m (EBIT 38.3m * (1 - 22.34%))
Current Ratio = 1.89 (Total Current Assets 237.5m / Total Current Liabilities 125.8m)
Debt / Equity = 1.03 (Debt 234.4m / totalStockholderEquity, last quarter 227.4m)
Debt / EBITDA = 2.96 (Net Debt 206.6m / EBITDA 69.7m)
Debt / FCF = 98.22 (Net Debt 206.6m / FCF TTM 2.10m)
Total Stockholder Equity = 210.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.04% (Net Income 18.1m / Total Assets 596.3m)
RoE = 8.63% (Net Income TTM 18.1m / Total Stockholder Equity 210.1m)
RoCE = 9.58% (EBIT 38.3m / Capital Employed (Equity 210.1m + L.T.Debt 189.2m))
RoIC = 7.55% (NOPAT 29.7m / Invested Capital 393.4m)
WACC = 6.05% (E(375.4m)/V(609.8m) * Re(9.12%) + D(234.4m)/V(609.8m) * Rd(1.44%) * (1-Tc(0.22)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.28%
[DCF Debug] Terminal Value 65.74% ; FCFE base≈7.27m ; Y1≈4.77m ; Y5≈2.18m
Fair Price DCF = 1.14 (DCF Value 36.1m / Shares Outstanding 31.5m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 58.40 | EPS CAGR: 91.80% | SUE: 2.58 | # QB: 1
Revenue Correlation: 47.44 | Revenue CAGR: 3.62% | SUE: 0.63 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.10 | Chg30d=+0.040 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.01 | Chg30d=+0.150 | Revisions Net=+1 | Growth EPS=+16.7% | Growth Revenue=+2.9%
Additional Sources for MG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle